Sangmo Hong Selected Research

Sangmo Hong Research Topics

6	Insulin Resistance 12/2022 - 11/2011
5	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2011
2	Obesity 01/2022 - 01/2022
2	Dyslipidemias (Dyslipidemia) 01/2022 - 01/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 11/2020
2	Diabetes Mellitus 03/2016 - 02/2011
1	Metabolic Diseases (Metabolic Disease) 12/2022
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Fatty Liver 01/2022
1	COVID-19 01/2021
1	Albuminuria 01/2021
1	Dementia (Dementias) 01/2021
1	Abdominal Obesity 01/2021
1	Gastritis 06/2020
1	Chronic Renal Insufficiency 01/2020
1	Hypoglycemia (Reactive Hypoglycemia) 01/2020
1	Vascular Diseases (Vascular Disease) 11/2019
1	Atherosclerosis 11/2019
1	Prediabetic State (Prediabetes) 04/2016
1	Latent Autoimmune Diabetes in Adults 11/2011
1	Hypertension (High Blood Pressure) 02/2011
1	Primary Hyperparathyroidism 11/2010

5	Triglycerides (Triacylglycerol)IBA 12/2022 - 11/2020
5	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 03/2016
2	ORALIT (ORS)IBA 01/2022 - 01/2021
2	Cilostazol (Pletal)FDA LinkGeneric 01/2022 - 11/2019
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2020
2	Insulin (Novolin)FDA Link 01/2021 - 11/2011
2	LipidsIBA 06/2020 - 02/2011
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Branched-Chain Amino AcidsIBA 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	lobeglitazoneIBA 01/2021
1	Pioglitazone (Actos)FDA Link 01/2021
1	CholesterolIBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021
1	LDL CholesterolIBA 01/2021
1	VaccinesIBA 01/2021
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2020
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 11/2019
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 04/2016
1	AutoantibodiesIBA 11/2011
1	Zinc Transporter 8IBA 11/2011
1	AntigensIBA 11/2011
1	CalciumIBA 11/2010

1	Therapeutics 01/2021